Permanent renal failure induced by pentastarch

NDT Plus

Volumn 1, Issue 5, 2008, Pages 322-325

  Jamal, Rahima ^a   Ghannoum, Marc ^b   Naud, Jean Francois ^a   Turgeon, Pierre Paul ^a   Leblanc, Martine ^a  

^a MAISONNEUVE ROSEMONT HOSPITAL   (Canada)

^b Verdun Hospital   (Canada)

Author keywords

Acute renal failure; Colloid; Hydroxyethyl starch; Pentastarch

Indexed keywords

CYCLOOXYGENASE 2 INHIBITOR; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FUROSEMIDE; GENTAMICIN; HETASTARCH;

ACUTE KIDNEY FAILURE; AGED; ANAMNESIS; ARTICLE; BRAIN DISEASE; CASE REPORT; CLINICAL FEATURE; HEMODIALYSIS; HEMOFILTRATION; HUMAN; HUMAN TISSUE; KIDNEY BIOPSY; KIDNEY FUNCTION; KIDNEY TUBULE CELL; MALE; METABOLIC ACIDOSIS; PRIORITY JOURNAL; UREMIA;

EID: 52449122065     PISSN: 17530784     EISSN: 17530792     Source Type: Journal    
DOI: 10.1093/ndtplus/sfn075     Document Type: Article

References (23)

1. Treib J, Baron J-F, Grauer MT et al. An international view of hydroxyethyl starches. Intensive Care Med 1999; 25: 258-268
2. Davidson IJ. Renal impact of fluid management with colloids: a comparative review. Eur J Anaesthesiol 2006; 23: 721-738
3. Boldt J. Hydroxyethylstarch as a risk factor for acute renal failure. Is a change of clinical practice indicated? Drug Saf 2002; 25: 837-846
4. Kief H, Englelhart K. Reabsorptive vacuolisation der gewundenen nierenhauptstuecke (sog. Osmotische nephrose). Frankf Z Pathol 1966; 75: 53-59
5. Iana A, Schwartz D. Renal tubular cellular and molecular events in acute renal failure. Nephron 1994; 68: 413-418
6. Boldt J. Intravascular volume replacement therapy with synthetic colloids: is there an influence on renal function. Anesth Analg 2003; 96: 376-382
7. Chinitz JL, Kim KE, Onesti G et al. Pathophysiology and prevention of dextran-40 induced anuria. J Lab Clin Med 1971; 77: 76-87
8. Druml W, Pölzleitner D, Laggner AN et al. Dextran-40, acute renal failure, and elevated plasma oncotic pressure. N Engl J Med 1988; 318: 252-253
9. Rozich JD, Paul RV. Acute renal failure precipitated by elevated colloid osmotic pressure. Am J Med 1989; 87: 358-360
10. Legendre C, Thervet E, Page B et al. Hydroxyethyl starch and osmotic-nephrosis-like lesions in kidney transplantation. Lancet 1993; 342: 248-249
11. DiScala VA, Mautner W, Cohen JA et al. Tubular alterations produces by osmotic diuresis with mannitol. Ann Intern Med 1965; 63: 767-775
12. Diomi P, Ericsson JL, Matheson NA. Effects of dextran 40 on urine flowand composition during renal hypoperfusion in dogs with osmotic nephrosis. Ann Surg 1970; 172: 813-824
13. Moreau JF, Noel LH, Droz D. Proximal renal tubular vacuolization induced by iodinated contrast media, or so-called osmotic nephrosis. Invest Radiol 1993; 28: 187-190
14. Ahsan N, Palmer BF, Wheeler D et al. Intravenous immunoglobulin-induced osmotic nephrosis. Arch Inter Med 1994; 154: 1985-1987
15. Schortgen F, Lacherade JC, Bruneel F et al. Effects of hydroxyethyl-starch and gelatin on renal function in severe sepsis: a multicentre randomized study. Lancet 2001; 357: 911-916
16. Jungheinrich C, Neff TA. Pharmacokinetics of hydroxyethyl starch. Clin Pharmacokinet 2005; 44: 681-699
17. De Labarthe A, Jacobs F, Blot F et al. Acute renal failure secondary to hydroxyethylstarch administration in a surgical patient. Am J Med 2001; 111: 417-418
18. Dickenmann MJ, Filipovic M, Schneider MC et al. Hydroxyethylstarch-associated transient acute renal failure after epidural anesthesia for labor analgesia and Caesarean section. Nephrol Dial Transplant 1998; 13: 2706
19. Vogt NH, Bothner U, Lerch G et al. Large dose administration of 6% hydroxyethyl starch 200/0,5 for total hip arthroplasty: plasma homeostasis, hemostasis, and renal function compared to use of 5% human albumin. Anesth Analg 1996; 83: 262-268
20. London MJ, Ho SJ, Triedman JK et al. A randomized clinical trial of 10% pentastarch (low molecular weight hydroxyethyl starch) versus 5% albumin for plasma volume expansion after cardiac operations. J Thorac Cardiovasc Surg 1997; 97: 785-797
21. Boldt J, Müller M, Mentges D et al. Volume therapy in the critically ill: is there a difference? Intensive Care Med 1998; 24: 28-36
22. Allison KP, Gosling P, Jones S et al. Randomized trial of hydroxyethyl starch versus gelatin for trauma resuscitation. J Trauma 1999; 14: 1517-1520
23. Brunkhorst FM, Engel C, Bloos F et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 2008; 358: 125-139